Brief: BioRestorative Therapies Announces First Patient Enrolled For The Company’s Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease (CLDD)
June 30 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ANNOUNCES FIRST PATIENT ENROLLED
FOR
THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE (CLDD)
Source text for Eikon: ID:nGNX6t4Y3G
Further company coverage: BRTX.O
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM